adamantane has been researched along with 2019 Novel Coronavirus Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitinger, HG; Breitinger, U; Fam, MS; Sedky, CA; Turky, NO | 1 |
| Cimolai, N | 1 |
| Grieb, P; Rejdak, K | 1 |
| Brenner, SR | 1 |
| Kwon, DY; Park, MH | 1 |
| Butterworth, RF | 1 |
1 review(s) available for adamantane and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Potential for the Repurposing of Adamantane Antivirals for COVID-19.
Topics: Adamantane; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Nervous System Diseases | 2021 |
5 other study(ies) available for adamantane and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites.
Topics: Adamantane; COVID-19; Flavonoids; HEK293 Cells; Humans; SARS-CoV-2; Viroporin Proteins | 2023 |
Potentially repurposing adamantanes for COVID-19.
Topics: Adamantane; Betacoronavirus; China; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Topics: Adamantane; Adult; Aged; Aged, 80 and over; Amantadine; Asymptomatic Infections; Betacoronavirus; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Multiple Sclerosis; Pandemics; Parkinson Disease; Pneumonia, Viral; Protective Factors; SARS-CoV-2; Severity of Illness Index | 2020 |
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
Topics: Adamantane; Amantadine; COVID-19; Humans; Lysosomes; Memantine; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Virus Replication | 2020 |
A retrospective review of memantine use and COVID-19-associated mortality from a national database.
Topics: Adamantane; COVID-19; Humans; Memantine; Retrospective Studies; SARS-CoV-2 | 2021 |